![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 28, 2021 6:20:13 AM
Do you believe AVIPTADIL/ZYESAMI could potentially substitute for Gabapentin and other anticonvulsant medication by blocking calcium channels and/or glutamatergen receptors?
Since Gabapentin (or Neurontin in the US) is prescribed for a very wide range of indications from seizures over neuropathic pain to psychiatric disorders whilst being quite toxic and only effective in 35% 0f patients this could possibly be the second most important future indication if this could be shown in trials!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM